OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
More than $1 out of every $9 under professional management in the United States is involved in socially responsible investing.
The biopharmaceutical sector can look forward to a financially flush venture funding environment in 2008
Closer examination shows there's a strong bond between the biotech market and the unraveling credit markets.
When you start out, keep your small-cap exposure to no more than 10% of your holdings, and gradually increase.